Evidence map›Paper›PMID 40271220›Full record

ArticleNAR cancer2025

The role of recurrent somatic mutations that alter conserved m

Oliver Artz, James R White, Benoit Rousseau, Guillem Argiles, Michael B Foote, Paul Johannet, Miteshkumar Patel, Somer Abdelfattah, Shrey Patel, Callahan Wilde and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in NAR cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Oliver ArtzDi vision of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering, New York City, NY 10065, United States.ORCID 0000-0002-5708-1281
James R WhiteResphera Biosciences, Baltimore, MD 21231, United States.
Benoit RousseauDi vision of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering, New York City, NY 10065, United States.
Guillem ArgilesDi vision of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering, New York City, NY 10065, United States.
Michael B FooteDi vision of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering, New York City, NY 10065, United States.
Paul JohannetDi vision of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering, New York City, NY 10065, United States.
Miteshkumar PatelDi vision of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering, New York City, NY 10065, United States.
Somer AbdelfattahDi vision of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering, New York City, NY 10065, United States.
Shrey PatelDi vision of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering, New York City, NY 10065, United States.
Callahan WildeDi vision of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering, New York City, NY 10065, United States.
David MielesDi vision of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering, New York City, NY 10065, United States.
Luis A DiazDi vision of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering, New York City, NY 10065, United States.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

N

Indexed as

AdenosineMutationNeoplasmsGene Expression Regulation, NeoplasticHumansAdenosineN-methyladenosine

Identifiers

PMID40271220
PMCPMC12015683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.